Accurate measurement of both ADAMTS13 antigen levels (via ELISA) and functional ADAMTS13 activity [via fluorescence resonance energy transfer based assay (FRETS-VWF73) and collagen-binding activity assay] are crucial to the management of TTP. Here, ADAMTS13 is linked to thrombotic thrombocytopenic purpura.